A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
However, physicians and chemists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.
Some professionals stated the popularity for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Removal
Based on the social media company, the platform has taken down violative content and banned associated hashtags and query recommendations. The company stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step guides for mixing or administering at residence.
Within moments of joining one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these groups, posts display dark colored packages with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering materials they can’t verify. Even if the science behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her team has already encountered patients harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to potentially serious medical dangers”.
